| 12390475 |
Dry powder treprostinil for the treatment of pulmonary hypertension |
Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor |
2025-08-19 |
| 11744835 |
Dry powder treprostinil for the treatment of pulmonary hypertension |
Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor |
2023-09-05 |
| 11744836 |
Dry powder treprostinil for the treatment of pulmonary hypertension |
Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor |
2023-09-05 |
| 11712442 |
Dry powder treprostinil for the treatment of pulmonary hypertension |
Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor |
2023-08-01 |
| 11660304 |
Dry powder treprostinil for the treatment of pulmonary hypertension |
Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor |
2023-05-30 |
| 11357782 |
Treprostinil administration by inhalation |
Horst Olschewski, Lewis J. Rubin, Thomas Schmehl, Werner Seeger, Carl Sterritt +1 more |
2022-06-14 |
| 11154210 |
Method of determining vasoreactivity using inhaled nitric oxide |
Tammy Watts, David H. Fine, Lewis J. Rubin |
2021-10-26 |
| 10898494 |
Dry powder treprostinil for the treatment of pulmonary hypertension |
Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor |
2021-01-26 |
| 10716793 |
Treprostinil administration by inhalation |
Horst Olschewski, Lewis J. Rubin, Thomas Schmehl, Werner Seeger, Carl Sterritt +1 more |
2020-07-21 |
| 10376525 |
Treprostinil administration by inhalation |
Horst Olschewski, Lewis J. Rubin, Thomas Schmehl, Werner Seeger, Carl Sterritt +1 more |
2019-08-13 |
| 9358240 |
Treprostinil administration by inhalation |
Horst Olschewski, Lewis J. Rubin, Thomas Schmehl, Werner Seeger, Carl Sterritt +1 more |
2016-06-07 |
| 9339507 |
Treprostinil administration by inhalation |
Horst Olschewski, Lewis J. Rubin, Thomas Schmehl, Werner Seeger, Carl Sterritt +1 more |
2016-05-17 |
| 8765813 |
Use of treprostinil to treat and prevent ischemic lesions |
Michael Wade, Roger Jeffs, Deborah Strootman, Kathryn Bronstein |
2014-07-01 |
| 6054486 |
Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease |
James Crow, Shelmer D. Blackburn, Jr., Michael Wade, Gilles Cloutier, Martine Rothblatt |
2000-04-25 |